The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Cryptococcosis-Global Market Insights and Sales Trends 2024
Synopsis
Cryptococcosis, also known as cryptococcal disease, is a potentially fatal fungal disease. It is caused by one of two species; Cryptococcus neoformans and Cryptococcus gattii
The global Cryptococcosis market size is expected to reach US$ 72550 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Cryptococcosis in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Cryptococcosis market. Amphotericin B (Amphocin and Fungizone), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Flucytosine (Ancobon) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cryptococcosis market, driven by demand from China, the second largest economy with some signs of stabilising, the Cryptococcosis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cryptococcosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cryptococcosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cryptococcosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cryptococcosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cryptococcosis covered in this report include Bristol-Myers Squibb, Johnson & Johnson, Abbott, Novartis, Pfizer, Bausch Health, Glenmark, Viamet Pharmaceuticals and Sigmapharm, etc.
The global Cryptococcosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
Johnson & Johnson
Abbott
Novartis
Pfizer
Bausch Health
Glenmark
Viamet Pharmaceuticals
Sigmapharm
Global Cryptococcosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cryptococcosis market, Segment by Type:
Amphotericin B (Amphocin and Fungizone)
Flucytosine (Ancobon)
Fluconazole (Diflucan)
Voriconazole
Global Cryptococcosis market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cryptococcosis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cryptococcosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Cryptococcosis, also known as cryptococcal disease, is a potentially fatal fungal disease. It is caused by one of two species; Cryptococcus neoformans and Cryptococcus gattii
The global Cryptococcosis market size is expected to reach US$ 72550 million by 2029, growing at a CAGR of 3.6% from 2023 to 2029. The market is mainly driven by the significant applications of Cryptococcosis in various end use industries. The expanding demands from the Hospital Pharmacies, Retail Pharmacies and Online Pharmacies,, are propelling Cryptococcosis market. Amphotericin B (Amphocin and Fungizone), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Flucytosine (Ancobon) segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Cryptococcosis market, driven by demand from China, the second largest economy with some signs of stabilising, the Cryptococcosis market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Cryptococcosis, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Cryptococcosis market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Cryptococcosis market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Cryptococcosis sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Cryptococcosis covered in this report include Bristol-Myers Squibb, Johnson & Johnson, Abbott, Novartis, Pfizer, Bausch Health, Glenmark, Viamet Pharmaceuticals and Sigmapharm, etc.
The global Cryptococcosis market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bristol-Myers Squibb
Johnson & Johnson
Abbott
Novartis
Pfizer
Bausch Health
Glenmark
Viamet Pharmaceuticals
Sigmapharm
Global Cryptococcosis market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Cryptococcosis market, Segment by Type:
Amphotericin B (Amphocin and Fungizone)
Flucytosine (Ancobon)
Fluconazole (Diflucan)
Voriconazole
Global Cryptococcosis market, by Application
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Cryptococcosis manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Cryptococcosis in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Cryptococcosis Market Overview
1.1 Cryptococcosis Product Overview
1.2 Cryptococcosis Market Segment by Type
1.2.1 Amphotericin B (Amphocin and Fungizone)
1.2.2 Flucytosine (Ancobon)
1.2.3 Fluconazole (Diflucan)
1.2.4 Voriconazole
1.3 Global Cryptococcosis Market Size by Type
1.3.1 Global Cryptococcosis Market Size Overview by Type (2018-2029)
1.3.2 Global Cryptococcosis Historic Market Size Review by Type (2018-2023)
1.3.3 Global Cryptococcosis Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Cryptococcosis Sales Breakdown by Type (2018-2023)
1.4.2 Europe Cryptococcosis Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Cryptococcosis Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Cryptococcosis Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Cryptococcosis Sales Breakdown by Type (2018-2023)
2 Global Cryptococcosis Market Competition by Company
2.1 Global Top Players by Cryptococcosis Sales (2018-2023)
2.2 Global Top Players by Cryptococcosis Revenue (2018-2023)
2.3 Global Top Players by Cryptococcosis Price (2018-2023)
2.4 Global Top Manufacturers Cryptococcosis Manufacturing Base Distribution, Sales Area, Product Type
2.5 Cryptococcosis Market Competitive Situation and Trends
2.5.1 Cryptococcosis Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Cryptococcosis Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Cryptococcosis as of 2022)
2.7 Date of Key Manufacturers Enter into Cryptococcosis Market
2.8 Key Manufacturers Cryptococcosis Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Cryptococcosis Status and Outlook by Region
3.1 Global Cryptococcosis Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Cryptococcosis Historic Market Size by Region
3.2.1 Global Cryptococcosis Sales in Volume by Region (2018-2023)
3.2.2 Global Cryptococcosis Sales in Value by Region (2018-2023)
3.2.3 Global Cryptococcosis Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Cryptococcosis Forecasted Market Size by Region
3.3.1 Global Cryptococcosis Sales in Volume by Region (2024-2029)
3.3.2 Global Cryptococcosis Sales in Value by Region (2024-2029)
3.3.3 Global Cryptococcosis Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Cryptococcosis by Application
4.1 Cryptococcosis Market Segment by Application
4.1.1 Hospital Pharmacies
4.1.2 Retail Pharmacies
4.1.3 Online Pharmacies
4.2 Global Cryptococcosis Market Size by Application
4.2.1 Global Cryptococcosis Market Size Overview by Application (2018-2029)
4.2.2 Global Cryptococcosis Historic Market Size Review by Application (2018-2023)
4.2.3 Global Cryptococcosis Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Cryptococcosis Sales Breakdown by Application (2018-2023)
4.3.2 Europe Cryptococcosis Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Cryptococcosis Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Cryptococcosis Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Cryptococcosis Sales Breakdown by Application (2018-2023)
5 North America Cryptococcosis by Country
5.1 North America Cryptococcosis Historic Market Size by Country
5.1.1 North America Cryptococcosis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Cryptococcosis Sales in Volume by Country (2018-2023)
5.1.3 North America Cryptococcosis Sales in Value by Country (2018-2023)
5.2 North America Cryptococcosis Forecasted Market Size by Country
5.2.1 North America Cryptococcosis Sales in Volume by Country (2024-2029)
5.2.2 North America Cryptococcosis Sales in Value by Country (2024-2029)
6 Europe Cryptococcosis by Country
6.1 Europe Cryptococcosis Historic Market Size by Country
6.1.1 Europe Cryptococcosis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Cryptococcosis Sales in Volume by Country (2018-2023)
6.1.3 Europe Cryptococcosis Sales in Value by Country (2018-2023)
6.2 Europe Cryptococcosis Forecasted Market Size by Country
6.2.1 Europe Cryptococcosis Sales in Volume by Country (2024-2029)
6.2.2 Europe Cryptococcosis Sales in Value by Country (2024-2029)
7 Asia-Pacific Cryptococcosis by Region
7.1 Asia-Pacific Cryptococcosis Historic Market Size by Region
7.1.1 Asia-Pacific Cryptococcosis Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Cryptococcosis Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Cryptococcosis Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Cryptococcosis Forecasted Market Size by Region
7.2.1 Asia-Pacific Cryptococcosis Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Cryptococcosis Sales in Value by Region (2024-2029)
8 Latin America Cryptococcosis by Country
8.1 Latin America Cryptococcosis Historic Market Size by Country
8.1.1 Latin America Cryptococcosis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Cryptococcosis Sales in Volume by Country (2018-2023)
8.1.3 Latin America Cryptococcosis Sales in Value by Country (2018-2023)
8.2 Latin America Cryptococcosis Forecasted Market Size by Country
8.2.1 Latin America Cryptococcosis Sales in Volume by Country (2024-2029)
8.2.2 Latin America Cryptococcosis Sales in Value by Country (2024-2029)
9 Middle East and Africa Cryptococcosis by Country
9.1 Middle East and Africa Cryptococcosis Historic Market Size by Country
9.1.1 Middle East and Africa Cryptococcosis Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Cryptococcosis Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Cryptococcosis Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Cryptococcosis Forecasted Market Size by Country
9.2.1 Middle East and Africa Cryptococcosis Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Cryptococcosis Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Bristol-Myers Squibb
10.1.1 Bristol-Myers Squibb Company Information
10.1.2 Bristol-Myers Squibb Introduction and Business Overview
10.1.3 Bristol-Myers Squibb Cryptococcosis Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Bristol-Myers Squibb Cryptococcosis Products Offered
10.1.5 Bristol-Myers Squibb Recent Development
10.2 Johnson & Johnson
10.2.1 Johnson & Johnson Company Information
10.2.2 Johnson & Johnson Introduction and Business Overview
10.2.3 Johnson & Johnson Cryptococcosis Sales, Revenue and Gross Margin (2018-2023)
10.2.4 Johnson & Johnson Cryptococcosis Products Offered
10.2.5 Johnson & Johnson Recent Development
10.3 Abbott
10.3.1 Abbott Company Information
10.3.2 Abbott Introduction and Business Overview
10.3.3 Abbott Cryptococcosis Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Abbott Cryptococcosis Products Offered
10.3.5 Abbott Recent Development
10.4 Novartis
10.4.1 Novartis Company Information
10.4.2 Novartis Introduction and Business Overview
10.4.3 Novartis Cryptococcosis Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Novartis Cryptococcosis Products Offered
10.4.5 Novartis Recent Development
10.5 Pfizer
10.5.1 Pfizer Company Information
10.5.2 Pfizer Introduction and Business Overview
10.5.3 Pfizer Cryptococcosis Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Pfizer Cryptococcosis Products Offered
10.5.5 Pfizer Recent Development
10.6 Bausch Health
10.6.1 Bausch Health Company Information
10.6.2 Bausch Health Introduction and Business Overview
10.6.3 Bausch Health Cryptococcosis Sales, Revenue and Gross Margin (2018-2023)
10.6.4 Bausch Health Cryptococcosis Products Offered
10.6.5 Bausch Health Recent Development
10.7 Glenmark
10.7.1 Glenmark Company Information
10.7.2 Glenmark Introduction and Business Overview
10.7.3 Glenmark Cryptococcosis Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Glenmark Cryptococcosis Products Offered
10.7.5 Glenmark Recent Development
10.8 Viamet Pharmaceuticals
10.8.1 Viamet Pharmaceuticals Company Information
10.8.2 Viamet Pharmaceuticals Introduction and Business Overview
10.8.3 Viamet Pharmaceuticals Cryptococcosis Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Viamet Pharmaceuticals Cryptococcosis Products Offered
10.8.5 Viamet Pharmaceuticals Recent Development
10.9 Sigmapharm
10.9.1 Sigmapharm Company Information
10.9.2 Sigmapharm Introduction and Business Overview
10.9.3 Sigmapharm Cryptococcosis Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Sigmapharm Cryptococcosis Products Offered
10.9.5 Sigmapharm Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Cryptococcosis Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Cryptococcosis Industrial Chain Analysis
11.4 Cryptococcosis Market Dynamics
11.4.1 Cryptococcosis Industry Trends
11.4.2 Cryptococcosis Market Drivers
11.4.3 Cryptococcosis Market Challenges
11.4.4 Cryptococcosis Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Cryptococcosis Distributors
12.3 Cryptococcosis Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
